Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -2.13% | 199.08 | 1.3% | $749.78m | |
| GILD | Gilead Sciences, Inc. | -2.66% | 62.51 | 0.9% | $372.82m | |
| CELG | Celgene Corporation | -1.80% | 93.99 | 1.3% | $323.19m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -6.61% | 115.33 | 2.0% | $295.67m | |
| ILMN | Illumina, Inc. | -3.17% | 279.44 | 3.5% | $272.03m | |
| BIIB | Biogen Inc. | -2.68% | 225.85 | 1.3% | $258.17m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.20% | 180.18 | 1.9% | $251.48m | |
| EXAS | Exact Sciences Corporation | -0.77% | 116.96 | 24.1% | $238.08m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.77% | 286.85 | 2.6% | $193.57m | |
| A | Agilent Technologies, Inc. | -3.01% | 69.58 | 1.6% | $188.95m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.54% | 93.61 | 14.7% | $184.96m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.12% | 75.76 | 4.3% | $97.12m | |
| INCY | Incyte Corporation | -4.27% | 81.91 | 2.5% | $90.56m | |
| GHDX | Genomic Health, Inc. | -0.35% | 73.26 | 1.8% | $81.69m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.36% | 97.59 | 5.0% | $71.75m |
Company Profile
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.